For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and CEO
(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshiaki Sai, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/
Daiichi Sankyo Appoints New Corporate Officers
Tokyo, Japan (March 1, 2011) – Daiichi Sankyo Company, Limited today announced the appointment of new corporate officers at Daiichi Sankyo Company, Limited and Daiichi Sankyo Healthcare Company, Limited, effective from April 1, 2011.
1. DAIICHI SANKYO CO., LTD.
New Position
|
Name
|
Current Position
|
Member of the Board
|
Hitoshi Matsuda
|
Member of the Board,
Senior Executive Officer
and Head of Administration Division
of Japan Company
|
Senior Executive Officer
Head of Business Intelligence Division
of Japan Company
and in charge of External Affairs
|
Akira Nagano
|
Senior Executive Officer
Head of Quality and Safety Management Division,
And Head of Business Intelligence
Division of Japan Company
|
Senior Executive Officer
Head of Administration Division of
Japan Company
|
Yoshikazu Takano
|
Senior Executive Officer
Head of Group CSR
and in charge of External Affairs
|
Senior Executive Officer
Head of Supply Chain Division
|
Yuki Sato
|
Executive Officer
Head of Pharmaceutical Technology
Division
|
Executive Officer
General Manager of Human Resources
Department,
Administration Division
of Japan Company
|
Kyohei Nonose
|
Executive Officer
Head of Group HR Strategy
|
Executive Officer
President of ASCA Company
|
Shuji Handa
|
Corporate Officer
President of ASCA Company
|
Executive Officer
Head of Quality and Safety Management Division
|
Haruhisa Kubota
|
Corporate Officer
General Manager of Pharmacovigilance
Department,
Quality and Safety Management Division
|
New Position
|
Name
|
Current Position
|
Corporate Officer
Head of Group HR Strategy
and Head of Group CSR
|
Sunao Manabe
|
Corporate Officer
General Manager of Global Project
Management Department, R&D Division
|
Corporate Officer
Head of Pharmaceutical Technology
Division
|
Katsumi Fujimoto
|
General Manager of
CM&C Planning Department,
Pharmaceutical Technology Division
|
Corporate Officer
General Manager of Japanese Business Management Department,
Administration Division
of Japan Company
|
Ryoji Nagasaka
|
General Manager of Japanese Business Management Department,
Administration Division
of Japan Company
|
Corporate Officer
General Manager of Supply Chain
Planning Department,
Supply Chain Division
|
Toshiaki Tojo
|
Corporate Officer
General Manager of Supply Chain
Technology Department,
Supply Chain Division
|
Corporate Adviser
|
Toru Kuroda
|
Executive Officer
Head of Supply Chain Division
|
President of
Daiichi Sankyo RD Associe Co., Ltd.
|
Hideyuki Haruyama
|
Corporate Officer, in charge of Research of R&D Division
|
*ASCA, which stands for Asia South & Central America, is an internal name.
2. DAIICHI SANKYO HEALTHCARE CO., LTD.
New Position
|
Name
|
Current Position
|
Member of the Board,
Executive Officer
Head of Sales Division
|
Yoshiki Nishii
|
Member of the Board,
Corporate Officer
Head of Sales Division
|
Member of the Board,
Corporate Officer
Corporate Planning Department
|
Katsuhiko Yoshida
|
Corporate Officer
Corporate Planning Department
|
Member of the Board
|
Kenji Tsunoda
|
Member of the Board,
Corporate Officer
General Manager of R&D Department
|
Corporate Officer
General Manager of Corporate
Administration Department
and Internal Audit Department
|
Michihiko Murakami
|
Corporate Officer
General Manager of Corporate
Administration Department
|
Corporate Officer
General Manager of R&D Department
and Research Center,
Manager of Research GroupⅠ
|
Eiichi Mafune
|
General Manager of Research Center
|
Corporate Officer
General Manager of
Sales Administration Department,
Sales Division
|
Yasuhiro Kawanaka
|
General Manager of
Sales Management Department,
Sales Division
|
Corporate Adviser
|
Koji Furikado
|
Corporate Officer
|
End